Thrombopoietin mimetics for systemic lupus erythematosus with antiphospholipid antibodies should be discussed separately

Lupus. 2018 Oct;27(11):1876-1877. doi: 10.1177/0961203318784654. Epub 2018 Jun 29.

Authors

M Kanda¹, T Atsumi¹

Affiliation

¹ Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University.

PMID: 29958500
DOI: 10.1177/0961203318784654

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Antiphospholipid / blood*
Antiphospholipid Syndrome / complications
Benzoates / adverse effects
Benzoates / pharmacology*
Humans
Hydrazines / adverse effects
Hydrazines / pharmacology*
Lupus Erythematosus, Systemic / complications
Purpura, Thrombocytopenic, Idiopathic / drug therapy*
Pyrazoles / adverse effects
Pyrazoles / pharmacology*
Receptors, Fc
Recombinant Fusion Proteins / adverse effects
Recombinant Fusion Proteins / pharmacology*
Thrombopoietin / adverse effects
Thrombopoietin / pharmacology*
Venous Thromboembolism / chemically induced

Substances

Antibodies, Antiphospholipid
Benzoates
Hydrazines
Pyrazoles
Receptors, Fc
Recombinant Fusion Proteins
Thrombopoietin
romiplostim
eltrombopag